New Key Statistics Module, Z-Score and F-Score
NAS:MEDS Key Ratios
| Market Cap $ M | 8.33 |
| Enterprise Value $ M | 15.05 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 9.87 |
| Price/Sales | 0.70 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 8.00 |
| EPS (TTM) $ | -23.22 |
| Beneish M-Score | -1.19 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.16 |
| EV-to-EBITDA | -1.26 |
| PEG | -- |
| Shares Outstanding M | 1.41 |
| Net Margin (%) | -200.85 |
| Operating Margin % | -86.78 |
| Pre-tax Margin (%) | -159.27 |
| Quick Ratio | 0.24 |
| Current Ratio | 0.24 |
| ROA % (ttm) | -195.86 |
| ROE % (ttm) | -731.86 |
| ROIC % (ttm) | -73.68 |
| Dividend Yield % | -- |
| Altman Z-Score | -6.86 |
MEDS Number of Guru Trades
MEDS Volume of Guru Trades
Gurus Latest Trades with NAS:MEDS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MEDS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Trxade Health Inc Insider Transactions
No Available Data
News about NAS:MEDS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers